MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00408-025-00841-3

Медицинская библиотека · Lung · 2025

Serum Cytokeratin 18 and Fragment as Biomarkers for Severity and Prognosis in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Liu Ming-Yan, Qu Kai-Xin, Ma Kai-Shu, Cheng Zhen-Yu, Cai Xiang, Miu Hai-Long, Liu Meng-Xue, Wang Yi-Qun, Zhao Hui, Zheng Ling, Fu Lin, Yang Jin

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Cytokeratin (CK)18 is present in the bronchi and alveolar epithelium of the lung, and its cleavage product, CK-18M30, serves as a biological marker of apoptosis. However, the specific roles of CK-18 and CK-18M30 in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) remain unclear.

METHODS

This study enrolled 289 patients with AECOPD who met the inclusion criteria. Demographic information and clinical characteristics of the patients were documented. A 3-year follow-up period was implemented to evaluate acute exacerbations and mortality. Serum CK-18 and CK-18M30 concentrations were measured using enzyme-linked immunosorbent assays.

RESULTS

Serum concentrations of CK-18/CK-18M30 at admission in patients with AECOPD were higher than those in the control group. As severity increased, serum CK-18/CK-18M30 levels increased progressively in AECOPD patients. Pearson's correlation analysis revealed that serum CK-18/CK-18M30 concentrations were positively correlated with several clinical parameters. Linear and logistic regression models demonstrated positive correlations between serum CK-18 and CK-18M30 levels at admission and severity scores. Furthermore, higher serum CK-18/CK-18M30 levels at admission were associated with increased frequency of death and acute exacerbation in patients with AECOPD within 3 years.

CONCLUSION

Serum CK-18/CK-18M30 levels at admission were positively correlated with severity and poor prognosis in patients with AECOPD within 3 years. Therefore, serum CK-18 and CK-18M30 concentrations may serve as novel diagnostic and prognostic biomarkers for patients with AECOPD.

Для цитирования: Liu Ming-Yan, Qu Kai-Xin, Ma Kai-Shu, Cheng Zhen-Yu, Cai Xiang, Miu Hai-Long, Liu Meng-Xue, Wang Yi-Qun, Zhao Hui, Zheng Ling, Fu Lin, Yang Jin. Serum Cytokeratin 18 and Fragment as Biomarkers for Severity and Prognosis in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.. Lung. 2025. DOI: 10.1007/s00408-025-00841-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.